Skip to Content

Alipogene Tiparvovec



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Lipid lowering agent

Treatment of familial lipoprotein lipase deficiency (LPLD)

Chemical Name

Human lipoprotein lipase (LPL) gene variant LPLS⁴⁴⁷X in a vector, containing - amongst other - a protein shell, which is derived from the adeno-associated virus serotype 1 (AAV1)

Foreign Names

  • Alipogenum tiparvovecum (Latin)
  • Alipogen tiparvovec (German)
  • Alipogène tiparvovec (French)
  • Alipogén tiparvovec (Spanish)

Generic Name

  • Alipogene Tiparvovec (OS: USAN)

Brand Names

  • Glybera
    uniQure, Germany; uniQure biopharma, Poland


OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.